Navigation Links
Personalized health care will revolutionize 21st century medicine, says NJIT professor
Date:2/6/2013

A closer look at personalized or point-of-care healthcare was the focus of a recent international conference in India organized and chaired by NJIT Distinguished Professor Atam Dhawan. The IEEE Engineering in Medicine and Biology Society (EMBS) International Special Topic Conference in point-of-care healthcare technologies, broadcast around the world, focused on topics ranging from 21st century medicine with new smart cross-and trans-disciplinary technologies to how wireless communications will change how physicians care for patients.

"The last century witnessed a technology revolution in medicine and health through instrumentation, computer and information and communication technologies," said Dhawan, an electrical engineer. "This revolution has continued into the 21st century innovations re-defining the relationship between patient and healthcare providers."

Conference trends included the following.

  • New smart cross and trans disciplinary biosensor, biomarker, and information and data communication technologies will become more widely used. These technologies, along with health monitoring and data analysis systems, address healthcare priorities in developing and developed economies. Among the key priorities: hypertension and cardiovascular diseases, diabetes, infectious disease, women's health during pregnancy and elderly healthcare.

  • As life expectancy increases, the global community will face new quality of life and healthcare challenges at an affordable cost. The most vital challenge to developing nations is providing minimal quality healthcare to rural communities.

  • Miniaturized devices and wireless communication will change dramatically how physicians and surgeons can care for patients and the role patients will need to take in their own health care.

  • The hope is that health care will become more personalized through the tailoring of interventions to individual patients.'/>"/>

Contact: Sheryl Weinstein
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Personalized medicine eliminates need for drug in 2 children
2. Report from the front lines of personalized reproductive medicine revolution
3. BodyMedia & FitOrbit Up the Ante in Personalized Weight Loss
4. Study advances use of stem cells in personalized medicine
5. Scanning innovation can improve personalized medicine
6. Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine
7. How to Differentiate Your Pharmaceutical Product in the Personalized Medicine Segment
8. Creating a future of personalized medicine: U-M forms joint venture for DNA diagnostics
9. Chromosomal translocations point the way toward personalized cancer care
10. Advances in personalized medicine for lung cancer
11. Healthy seeds -- treated environmentally friendly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... today announced that members of the executive management team will ... 43rd Annual Technology, Media and Telecom Conference Date: May ... in Boston, MA Cowen ... 2015 Time: 2:45pm ET Location: The New York Palace Hotel, ...
(Date:4/27/2015)... 27, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... customers the first week of May, 2015 and will ... May. Gino Pereira , Chief ... the company as Wocket® enters the consumer market. We ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... study, scientists sampled the presence of 20 species of ... in the Adirondack Park. Calculating their occurrence at increasing ... are 36 percent more likely to occur near the ... that "human-sensitive" species were 26 percent less likely. Beyond ...
... of Nottingham has been used in a breakthrough study ... fully functioning fetal heart. The abdominal fetal ECG ... of Electrical and Electronic Engineering and on commercial sale ... company Monica Healthcare Ltd, has been used to observe ...
... to replace artificial preservatives in bread, making it tastier., ... mould fermented in sourdough bread, Michael Ganzle, professor and ... of Agricultural, Food and Nutritional Science and fellow researchers ... keep bread fresh without changing its flavour. Preservatives ...
Cached Biology News:WCS Adirondack Park study shows exurban residences impact bird communities up to 200 meters away 2WCS Adirondack Park study shows exurban residences impact bird communities up to 200 meters away 3Nottingham technology in heart development breakthrough 2Nottingham technology in heart development breakthrough 3Nottingham technology in heart development breakthrough 4
(Date:5/26/2015)... China , May 26, 2015 Tianyin ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), announced that the Company,s Annual Meeting of Shareholders ... scheduled to be held at the Company,s office located ... conference call, at 9:00 AM (local time in ...
(Date:5/26/2015)... May 26, 2015  A simple blood test developed ... to detect early Alzheimer,s disease is a step closer ... Detailed standardized guidelines that are needed before a blood ... in Alzheimer,s & Dementia . The guidelines establish ... working group that includes UNT Health Science Center. ...
(Date:5/26/2015)... Mr. Kevin Xu , President of MEBO International, on ... and President Bill Clinton for their sympathy and ... Rongxiang Xu , Kevin,s father. As a ... Dr. Xu,s commitment to the advancement of science and his ... be forgotten. As a renowned life scientist, Dr. Xu devoted ...
(Date:5/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ), ... has completed the acquisition of Pharmacyclics, Inc. enhancing ... is a leader in the hematological oncology market ... treat hematological cancers, a $24 billion global market. ... AbbVie,s broad late-stage oncology pipeline, has the potential ...
Breaking Biology Technology:TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2Dr. Rongxiang Xu, Beyond A Legend 2AbbVie Completes Acquisition of Pharmacyclics 2AbbVie Completes Acquisition of Pharmacyclics 3AbbVie Completes Acquisition of Pharmacyclics 4AbbVie Completes Acquisition of Pharmacyclics 5AbbVie Completes Acquisition of Pharmacyclics 6
... In its anniversary year joimax® presents numerous ... opening up the series of the big autumn congresses ... presents the now complete product range for endoscopic spinal ... new Multiuse-Set comprises instruments for endoscopic facet joint denervation ...
... -- Third ocular product partnered with ... Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: ... the US Food and Drug Administration (FDA) has approved ... I/IIa clinical development of UshStat ® , a novel ...
... Sutro Biopharma, a biopharmaceutical company developing novel ... today announced that the company,s proprietary biochemical protein ... of novel protein therapeutics will be presented at ... Trevor Hallam, Ph.D., chief scientific officer of Sutro, ...
Cached Biology Technology:joimax® Launches Numerous Innovations at EuroSpine Milan From 19 To 21 October 2011 2Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B 2Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B 3Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B 4Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin 2